The Bulletin of Experimental Treatments for AIDS is your bright and brainy source on new developments in HIV prevention, evolving approaches to HIV treatment, and strategies for living well with the virus.
Sign up for our newsletter to get the latest info on HIV and AIDS:
I remember feeling confused and angry the first few times I was blocked or rejected by an online prospect who said they were on PrEP. I was confused, because—in every … Read More
The number of people using tenofovir/emtricitabine (Truvada) for PrEP exceeded 77,000 in 2016, according to new numbers from AIDSVu, released in conjunction with the 2018 Conference on Retroviruses and Opportunistic … Read More
Pre-exposure prophylaxis (PrEP) and other news about HIV transmission and prevention were among the tops stories at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) held in March … Read More
A common theme in stories from those who use PrEP is how this biomedical prevention tool has decreased HIV-related stigma and lessened the divide between HIV-negative and HIV-positive people. Qualitative … Read More
A new event series in San Francisco called “PrEP Rallies” are smoothing the path to HIV treatment, PrEP and other health services for young Black men. Held at the health … Read More
PrEP is an effective method of preventing HIV that is available and can be affordable to most people who want to use it. But not everyone at risk for HIV … Read More
See more articles on the BETA Blog...